Is BBNX or ELMD more profitable?

Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of -65.31%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity. Company Net Margins Return on Equity Return on Assets Beta Bionics -65.31% -27.33% -24.28% Electromed 11.34% 15.71% 13.37%

Does the media prefer BBNX or ELMD?

In the previous week, Beta Bionics and Beta Bionics both had 7 articles in the media. Beta Bionics' average media sentiment score of 0.50 beat Electromed's score of 0.21 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Electromed 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ELMD or KIDS?

In the previous week, Electromed had 4 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Electromed and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.04 beat Electromed's score of 0.21 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer VREX or ELMD?

In the previous week, Electromed had 5 more articles in the media than Varex Imaging. MarketBeat recorded 7 mentions for Electromed and 2 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.91 beat Electromed's score of 0.21 indicating that Varex Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Varex Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Electromed 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, INMD or ELMD?

InMode has higher revenue and earnings than Electromed. InMode is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.06 $93.83M $1.23 10.79 Electromed $75.57M 2.67 $5.15M $1.38 17.62

Is INMD or ELMD more profitable?

InMode has a net margin of 19.94% compared to Electromed's net margin of 11.34%. Electromed's return on equity of 15.71% beat InMode's return on equity. Company Net Margins Return on Equity Return on Assets InMode 19.94% 11.52% 10.16% Electromed 11.34% 15.71% 13.37%

Does the media prefer INMD or ELMD?

In the previous week, InMode had 4 more articles in the media than Electromed. MarketBeat recorded 11 mentions for InMode and 7 mentions for Electromed. InMode's average media sentiment score of 0.30 beat Electromed's score of 0.21 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to DCTH or ELMD?

In the previous week, Delcath Systems had 31 more articles in the media than Electromed. MarketBeat recorded 38 mentions for Delcath Systems and 7 mentions for Electromed. Delcath Systems' average media sentiment score of 0.74 beat Electromed's score of 0.21 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 10 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Electromed 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Electromed (ELMD) Competitors

$24.32 -0.65 (-2.60%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$24.34 +0.02 (+0.08%)

As of 11/13/2026 07:30 PM Eastern

Compare

ELMD vs. BBNX, KIDS, VREX, INMD, and DCTH

Should you buy Electromed stock or one of its competitors? Electromed's main competitors and comparable companies include Beta Bionics (BBNX), OrthoPediatrics (KIDS), Varex Imaging (VREX), InMode (INMD), and Delcath Systems (DCTH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Electromed compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Beta Bionics and Beta Bionics both had 7 articles in the media. Beta Bionics' average media sentiment score of 0.50 beat Electromed's score of 0.21 indicating that Beta Bionics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beta Bionics	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Electromed	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of -65.31%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-65.31%	-27.33%	-24.28%
Electromed	11.34%	15.71%	13.37%

40.8% of Electromed shares are owned by institutional investors. 5.3% of Beta Bionics shares are owned by insiders. Comparatively, 11.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Electromed has lower revenue, but higher earnings than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	8.91	-$73.20M	-$1.84	N/A
Electromed	$75.57M	2.67	$5.15M	$1.38	17.62

Beta Bionics has a beta of 3.44, suggesting that its stock price is 244% more volatile than the broader market. Comparatively, Electromed has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

Beta Bionics presently has a consensus price target of $23.69, suggesting a potential upside of 44.29%. Electromed has a consensus price target of $43.75, suggesting a potential upside of 79.89%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.67
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Electromed beats Beta Bionics on 9 of the 15 factors compared between the two stocks.

How does Electromed compare to OrthoPediatrics?

Electromed (NYSE:ELMD) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

40.8% of Electromed shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 11.0% of Electromed shares are owned by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to OrthoPediatrics' net margin of -12.83%. Electromed's return on equity of 15.71% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
OrthoPediatrics	-12.83%	-8.10%	-5.46%

Electromed has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Electromed currently has a consensus price target of $43.75, suggesting a potential upside of 79.89%. OrthoPediatrics has a consensus price target of $30.75, suggesting a potential downside of 4.95%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Electromed has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$75.57M	2.67	$5.15M	$1.38	17.62
OrthoPediatrics	$236.35M	3.57	-$39.65M	-$1.43	N/A

In the previous week, Electromed had 4 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Electromed and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.04 beat Electromed's score of 0.21 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Electromed beats OrthoPediatrics on 8 of the 15 factors compared between the two stocks.

How does Electromed compare to Varex Imaging?

Varex Imaging (NASDAQ:VREX) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Varex Imaging presently has a consensus price target of $16.88, suggesting a potential downside of 6.77%. Electromed has a consensus price target of $43.75, suggesting a potential upside of 79.89%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Varex Imaging	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Electromed has a net margin of 11.34% compared to Varex Imaging's net margin of 2.55%. Electromed's return on equity of 15.71% beat Varex Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Varex Imaging	2.55%	9.19%	4.13%
Electromed	11.34%	15.71%	13.37%

Electromed has lower revenue, but higher earnings than Varex Imaging. Electromed is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Varex Imaging	$844.60M	0.91	-$70.30M	$0.52	34.81
Electromed	$75.57M	2.67	$5.15M	$1.38	17.62

In the previous week, Electromed had 5 more articles in the media than Varex Imaging. MarketBeat recorded 7 mentions for Electromed and 2 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.91 beat Electromed's score of 0.21 indicating that Varex Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Varex Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Electromed	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Varex Imaging has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market. Comparatively, Electromed has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

40.8% of Electromed shares are owned by institutional investors. 4.6% of Varex Imaging shares are owned by insiders. Comparatively, 11.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Electromed beats Varex Imaging on 13 of the 16 factors compared between the two stocks.

How does Electromed compare to InMode?

InMode (NASDAQ:INMD) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

68.0% of InMode shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 11.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

InMode presently has a consensus price target of $16.33, indicating a potential upside of 23.08%. Electromed has a consensus price target of $43.75, indicating a potential upside of 79.89%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, InMode had 4 more articles in the media than Electromed. MarketBeat recorded 11 mentions for InMode and 7 mentions for Electromed. InMode's average media sentiment score of 0.30 beat Electromed's score of 0.21 indicating that InMode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Electromed	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InMode has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market. Comparatively, Electromed has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

InMode has higher revenue and earnings than Electromed. InMode is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.06	$93.83M	$1.23	10.79
Electromed	$75.57M	2.67	$5.15M	$1.38	17.62

InMode has a net margin of 19.94% compared to Electromed's net margin of 11.34%. Electromed's return on equity of 15.71% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	19.94%	11.52%	10.16%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats InMode on 9 of the 16 factors compared between the two stocks.

How does Electromed compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Delcath Systems has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market. Comparatively, Electromed has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

Electromed has lower revenue, but higher earnings than Delcath Systems. Electromed is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	8.39	$2.70M	$0.16	128.44
Electromed	$75.57M	2.67	$5.15M	$1.38	17.62

Electromed has a net margin of 11.34% compared to Delcath Systems' net margin of 6.05%. Electromed's return on equity of 15.71% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	6.05%	5.56%	4.98%
Electromed	11.34%	15.71%	13.37%

Delcath Systems currently has a consensus price target of $29.33, suggesting a potential upside of 42.74%. Electromed has a consensus price target of $43.75, suggesting a potential upside of 79.89%. Given Electromed's higher probable upside, analysts clearly believe Electromed is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 11.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Delcath Systems had 31 more articles in the media than Electromed. MarketBeat recorded 38 mentions for Delcath Systems and 7 mentions for Electromed. Delcath Systems' average media sentiment score of 0.74 beat Electromed's score of 0.21 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	10 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Electromed	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Delcath Systems beats Electromed on 10 of the 17 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELMD vs. The Competition

Export

Metric	Electromed	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$201.54M	$5.96B	$7.84B	$23.48B
Dividend Yield	N/A	1.69%	2.46%	3.79%
P/E Ratio	32.43	37.11	34.39	25.65
Price / Sales	2.67	5.57	8.73	3.32
Price / Cash	41.36	23.95	21.93	15.51
Price / Book	4.77	4.45	4.35	3.72
Net Income	$5.15M	$143.14M	$3.51B	$1.08B
7 Day Performance	-10.49%	-1.26%	-1.50%	0.57%
1 Month Performance	-11.50%	-1.31%	-2.56%	1.11%
1 Year Performance	-3.76%	1.72%	0.92%	7.21%

Electromed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELMD Electromed	2.1365 of 5 stars	$24.32 -2.6%	$43.75 +79.9%	-7.7%	$201.54M	$75.57M	32.43	197	Gap Down
BBNX Beta Bionics	3.1767 of 5 stars	$16.62 -1.9%	$23.69 +42.5%	-37.4%	$902.11M	$100.25M	N/A	423	Gap Down
KIDS OrthoPediatrics	2.7382 of 5 stars	$33.60 -1.1%	$30.75 -8.5%	+91.2%	$877.30M	$236.35M	N/A	602	Positive News
VREX Varex Imaging	1.4961 of 5 stars	$18.45 0.0%	$16.88 -8.5%	+50.6%	$783.18M	$844.60M	35.47	2,400	Upcoming Earnings
INMD InMode	2.499 of 5 stars	$13.27 -1.8%	$16.00 +20.6%	-7.2%	$762.24M	$370.49M	10.78	660	Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELMD) was last updated on 11/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Electromed (ELMD) Competitors

ELMD vs. BBNX, KIDS, VREX, INMD, and DCTH

How does Electromed compare to Beta Bionics?

Summary

How does Electromed compare to OrthoPediatrics?

Summary

How does Electromed compare to Varex Imaging?

Summary

How does Electromed compare to InMode?

Summary

How does Electromed compare to Delcath Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Electromed (ELMD) Competitors

ELMD vs. BBNX, KIDS, VREX, INMD, and DCTH

How does Electromed compare to Beta Bionics?

Does the media prefer BBNX or ELMD?

Is BBNX or ELMD more profitable?

Do institutionals and insiders hold more shares of BBNX or ELMD?

Which has better valuation & earnings, BBNX or ELMD?

Which has more volatility & risk, BBNX or ELMD?

Do analysts rate BBNX or ELMD?

Summary

How does Electromed compare to OrthoPediatrics?

Do institutionals & insiders hold more shares of ELMD or KIDS?

Is ELMD or KIDS more profitable?

Which has more volatility & risk, ELMD or KIDS?

Do analysts recommend ELMD or KIDS?

Which has preferable earnings & valuation, ELMD or KIDS?

Does the media favor ELMD or KIDS?

Summary

How does Electromed compare to Varex Imaging?

Do analysts rate VREX or ELMD?

Is VREX or ELMD more profitable?

Which has stronger valuation & earnings, VREX or ELMD?

Does the media prefer VREX or ELMD?

Which has more risk & volatility, VREX or ELMD?

Do insiders & institutionals have more ownership in VREX or ELMD?

Summary

How does Electromed compare to InMode?

Do institutionals and insiders have more ownership in INMD or ELMD?

Do analysts prefer INMD or ELMD?

Does the media prefer INMD or ELMD?

Which has more risk and volatility, INMD or ELMD?

Which has higher valuation & earnings, INMD or ELMD?

Is INMD or ELMD more profitable?

Summary

How does Electromed compare to Delcath Systems?

Which has more risk & volatility, DCTH or ELMD?

Which has higher earnings & valuation, DCTH or ELMD?

Is DCTH or ELMD more profitable?

Do analysts rate DCTH or ELMD?

Do insiders & institutionals hold more shares of DCTH or ELMD?

Does the media refer more to DCTH or ELMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD vs. The Competition

Electromed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools